Sinopharm
1099.HK
₹191.70
Share price
-0.46%
Change (1 day)
-16.42%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Revenue for Sinopharm (1099.HK)
Revenue in 2023 (TTM): ₹5.089 Trillion
According to Sinopharm's latest financial reports the company's current revenue (TTM 
) is ₹7.204 Trillion. an increase over the revenue in the year 2022 that were of ₹6.833 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sinopharm from 2006 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | ₹7.204 T | 5.42% |
| 2022 | ₹6.833 T | -2.1% |
| 2021 | ₹6.979 T | 16.85% |
| 2020 | ₹5.973 T | 14.95% |
| 2019 | ₹5.196 T | 21.52% |
| 2018 | ₹4.276 T | 5.93% |
| 2017 | ₹4.036 T | 27.22% |
| 2016 | ₹3.173 T | 5.37% |
| 2015 | ₹3.011 T | 9.14% |
| 2014 | ₹2.758 T | 17.22% |
| 2013 | ₹2.353 T | 25.94% |
| 2012 | ₹1.868 T | 34.61% |
| 2011 | ₹1.388 T | 55.34% |
| 2010 | ₹893.74 B | 35.79% |
| 2009 | ₹658.18 B | 37.56% |
| 2008 | ₹478.48 B | 31.43% |
| 2007 | ₹364.07 B | 40.26% |
| 2006 | ₹259.56 B |